Wells Fargo Initiates Coverage of Globus Medical (GMED) with an Overweight Rating

Globus Medical, Inc. (NYSE:GMED) is 1 of the

8 Best Debt Free Stocks to Buy Right Now. On March 18, 2026, Wells Fargo assumed sum of Globus Medical, Inc. (NYSE:GMED) with an Overweight standing and a $104 terms target, portion maintaining its rating, terms target, and estimates.

Last month, Globus Medical, Inc. (NYSE:GMED) reported fourth-quarter EPS of $1.28, supra the 96c statement estimate, with gross of $826.4M compared to the $803.29M consensus. Chief Executive Officer Keith Pfeil said momentum “accelerated successful the 4th quarter,” pointing to double-digit income and net maturation and enlargement crossed the company’s portfolio, including its spine business, supported by disciplined execution. Pfeil added that the institution is focused connected sustaining maturation done merchandise launches, expanding its income force, and improving outcomes done its surgical ecosystem.

Copyright: nimon / 123RF Stock Photo

Globus Medical, Inc. (NYSE:GMED) raised its FY26 EPS outlook to $4.40-$4.50 from $4.30-$4.40, supra the $4.24 consensus, and expects FY26 gross of $3.18B-$3.22B compared to the $3.16B consensus.

Globus Medical, Inc. (NYSE:GMED) develops and commercializes healthcare solutions for musculoskeletal disorders globally.

While we admit the imaginable of GMED arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and 15 Stocks That Will Make You Rich successful 10 Years.

Disclosure: None. Follow Insider Monkey connected Google News.